1,298
Views
20
CrossRef citations to date
0
Altmetric
Report

Paclitaxel-induced aberrant mitosis and mitotic slippage efficiently lead to proliferative death irrespective of canonical apoptosis and p53

, , &
Pages 3268-3277 | Received 08 Sep 2016, Accepted 23 Sep 2016, Published online: 07 Nov 2016

References

  • Gascoigne KE, Taylor SS. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 2008; 14:111-22; PMID:18656424; http://dx.doi.org/10.1016/j.ccr.2008.07.002
  • Blagosklonny MV. Mitotic arrest and cell fate: why and how mitotic inhibition of transcription drives mutually exclusive events. Cell Cycle 2007; 6:70-4; PMID:17245109; http://dx.doi.org/10.4161/cc.6.1.3682
  • Wan L, Tan M, Yang J, Inuzuka H, Dai X, Wu T, Liu J, Shaik S, Chen G, Deng J, et al. APC(Cdc20) suppresses apoptosis through targeting bim for ubiquitination and destruction. Dev Cell 2014; 29:377-91; PMID:24871945; http://dx.doi.org/10.1016/j.devcel.2014.04.022
  • Díaz-Martínez LA, Karamysheva ZN, Warrington R, Li B, Wei S, Xie X-J, Roth MG, Yu H. Genome-wide siRNA screen reveals coupling between mitotic apoptosis and adaptation. EMBO J 2014; 33:1960-76; PMID:25024437; http://dx.doi.org/10.15252/embj.201487826
  • Wang P, Lindsay J, Owens TW, Mularczyk EJ, Warwood S, Foster F, Streuli CH, Brennan K, Gilmore AP. Phosphorylation of the proapoptotic BH3-only protein bid primes mitochondria for apoptosis during mitotic arrest. Cell Reports 2014; 7:661-71; PMID:24767991; http://dx.doi.org/10.1016/j.celrep.2014.03.050
  • Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ, Helgason E, Ernst JA, Eby M, Liu J, et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011; 471:110-4; PMID:21368834; http://dx.doi.org/10.1038/nature09779
  • Zhu Y, Zhou Y, Shi J. Post-slippage multinucleation renders cytotoxic variation in anti-mitotic drugs that target the microtubules or mitotic spindle. Cell Cycle 2014; 13:1756-64; PMID:24694730; http://dx.doi.org/10.4161/cc.28672
  • Uetake Y, Sluder G. Prolonged prometaphase blocks daughter cell proliferation despite normal completion of mitosis. Curr Biol 2010; 20:1666-71; PMID:20832310; http://dx.doi.org/10.1016/j.cub.2010.08.018
  • Orth JD, Loewer A, Lahav G, Mitchison TJ. Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction. Mol Biol Cell 2012; 23:567-76; PMID:22171325; http://dx.doi.org/10.1091/mbc.E11-09-0781
  • Blagosklonny MV. Prolonged mitosis versus tetraploid checkpoint: how p53 measures the duration of mitosis. Cell Cycle 2006; 5:971-5; PMID:16687915; http://dx.doi.org/10.4161/cc.5.9.2711
  • Chen J-G, Horwitz SB. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res 2002; 62:1935-8; PMID:11929805
  • Brito DA, Yang Z, Rieder CL. Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied. J Cell Biol 2008; 182:623-9; PMID:18710927; http://dx.doi.org/10.1083/jcb.200805072
  • Yang Z, Kenny AE, Brito DA, Rieder CL. Cells satisfy the mitotic checkpoint in Taxol, and do so faster in concentrations that stabilize syntelic attachments. J Cell Biol 2009; 186:675-84; PMID:19720871; http://dx.doi.org/10.1083/jcb.200906150
  • Santaguida S, Amon A. Short- and long-term effects of chromosome mis-segregation and aneuploidy. Nat Rev Mol Cell Biol 2015; 16:473-85; PMID:26204159; http://dx.doi.org/10.1038/nrm4025
  • Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer 2010; 10:194-204; PMID:20147901; http://dx.doi.org/10.1038/nrc2803
  • Watanabe A, Yasuhira S, Inoue T, Kasai S, Shibazaki M, Takahashi K, Akasaka T, Masuda T, Maesawa C. BCL2 and BCLxL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells. Exp Dermatol 2013; 22:518-23; PMID:23802633; http://dx.doi.org/10.1111/exd.12185
  • Brown JM, Wouters BG. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 1999; 59:1391-9; PMID:11512523; http://dx.doi.org/10.1054/drup.2001.0193
  • Roninson IB, Broude EV, Chang BD. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001; 4:303-13; PMID:11991684; http://dx.doi.org/10.1054/drup.2001.0213
  • Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63:1129-36; PMID:2175676
  • Hoppe-Seyler F, Butz K. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J Virol 1993; 67:3111-7; PMID:8388491
  • Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, et al. Fiji: an open-source platform for biological-image analysis. Nat Meth 2012; 9:676-82; PMID:22743772; http://dx.doi.org/10.1038/nmeth.2019
  • Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H, Kashiwagi S, Fukami K, Miyata T, Miyoshi H, et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 2008; 132:487-98; PMID:18267078; http://dx.doi.org/10.1016/j.cell.2007.12.033
  • Sakaue-Sawano A, Kobayashi T, Ohtawa K, Miyawaki A. Drug-induced cell cycle modulation leading to cell-cycle arrest, nuclear mis-segregation, or endoreplication. BMC Cell Biol 2011; 12:2; PMID:21226962; http://dx.doi.org/10.1186/1471-2121-12-2
  • Albeck JG, Burke JM, Aldridge BB, Zhang M, Lauffenburger DA, Sorger PK. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol Cell 2008; 30:11-25; PMID:18406323; http://dx.doi.org/10.1016/j.molcel.2008.02.012
  • Weaver BAA, Cleveland DW. Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell 2005; 8:7-12; PMID:16023594; http://dx.doi.org/10.1016/j.ccr.2005.06.011
  • Demidenko ZN, Kalurupalle S, Hanko C, Lim C-U, Broude E, Blagosklonny MV. Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis. Oncogene 2008; 27:4402-10; PMID:18469851; http://dx.doi.org/10.1038/onc.2008.82
  • Cassimeris L, Morabito J. TOGp, the human homolog of XMAP215/Dis1, is required for centrosome integrity, spindle pole organization, and bipolar spindle assembly. Mol Biol Cell 2004; 15:1580-90; PMID:14718566; http://dx.doi.org/10.1091/mbc.E03-07-0544
  • Skoufias DA, DeBonis S, Saoudi Y, Lebeau L, Crevel I, Cross R, Wade RH, Hackney D, Kozielski F. S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression. J Biol Chem 2006; 281:17559-69; PMID:16507573; http://dx.doi.org/10.1074/jbc.M511735200
  • Torres K, Horwitz SB. Mechanisms of Taxol-induced Cell Death Are Concentration Dependent. Cancer Res 1998; 58:3620-6; PMID:9721870
  • Giannakakou P, Robey R, Fojo T, Blagosklonny MV. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 2001; 20:3806-13; PMID:11439344; http://dx.doi.org/10.1038/sj.onc.1204487
  • Rieder CL, Maiato H. Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 2004; 7:637-51; PMID:15525526; http://dx.doi.org/10.1016/j.devcel.2004.09.002

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.